Use And Effect Of Raktamitraka In Pandu Roga (ANAEMIA)

A Comparative Pharmaceutico-Analytical Study And Clinical Efficacy Of Raktamitrarka W.S.R. To Pandu Roga (Anaemia) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065844

Enrollment

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D649- Anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Sign and symptoms of Anaemia. Evidence of Anaemia by lab investigations. Participates in age group of 18-70 years. Patients with Anaemia between 06gm %-10gm % of Haemoglobin

Exclusion criteria

Exclusion criteria: Patients suffered with serious cardiac disorders like MI, Cardiac failure and Crisis Patients having life threatening disease. Patient having major illness like IDDM, DM which is poorly controlled or newly diagnosed or is taking new therapy or recently adjusted therapy. Patient having Carcinoma. Pregnant lady. Patient with severe Anaemia below 06 gm% of Haemoglobin. Patient suffering with Thalassemia, Bone marrow disorders, autoimmune disorders and Iron toxicity. Patient himself or herself wants to withdraw from the clinical trial.

Design outcomes

Primary

Measure	Time frame
Change in Quantity of HaemoglobinTimepoint: 60 days	—

Secondary

Measure	Time frame
Anemia scale will be assessedTimepoint: 15 days,30 days & 45 days	—

Countries

India

Contacts

Public ContactDr Sandeep

MMM.Goverment Ayurveda College Udaipur

sharmadrajay@yahoo.com9413257535

Outcome results